弱精子症诊疗中国专家共识

2021-07-30 中国医师协会生殖医学专业委员会 中华生殖与避孕杂志

弱精子症是男性不育最常见的类型之一,是复杂多因素作用的结果,有30%~40%的病例无法明确病因和发病机制。

中文标题:

弱精子症诊疗中国专家共识

发布日期:

2021-07-30

简要介绍:

弱精子症是男性不育最常见的类型之一,是复杂多因素作用的结果,有30%~40%的病例无法明确病因和发病机制。有鉴于此,中国医师协会生殖医学专业委员会生殖男科学组组织了生殖男科领域的专家,从弱精子症的病因、诊断流程以及个体化治疗方案等多个方面进行了深入的探讨。主要内容包括基于2次及以上精液检测结果的弱精子症分级标准;建议进行精子存活率检测、形态学分析、阴囊超声检查、经直肠超声检查和遗传学检测等明确弱精子症的病因;推荐针对弱精子症病因的治疗,经验性治疗以及辅助生殖技术助孕。本共识可为从事生殖医学、男科学的专业医务人员提供专家咨询建议和诊疗参考方案。

相关资料下载:
[AttachmentFileName(sort=1, fileName=弱精子症诊疗中国专家共识.pdf)] GetToolGuiderByIdResponse(projectId=1, id=15aef1c00219a4f7, title=弱精子症诊疗中国专家共识, enTitle=, guiderFrom=中华生殖与避孕杂志, authorId=0, author=, summary=弱精子症是男性不育最常见的类型之一,是复杂多因素作用的结果,有30%~40%的病例无法明确病因和发病机制。, cover=https://img.medsci.cn/2021927/1632757114910_5579292.jpg, journalId=0, articlesId=null, associationId=1403, associationName=中国医师协会生殖医学专业委员会, associationIntro=, copyright=0, guiderPublishedTime=Fri Jul 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<p><span style="color: #373737;">弱精子症是男性不育最常见的类型之一,是复杂多因素作用的结果,有30%~40%的病</span><span style="color: #373737;">例无法明确病因和发病机制。有鉴于此,中国医师协会生殖医学专业委员会生殖男科学组组织了生</span><span style="color: #373737;">殖男科领域的专家,从弱精子症的病因、诊断流程以及个体化治疗方案等多个方面进行了深入的探</span><span style="color: #373737;">讨。主要内容包括基于2次及以上精液检测结果的弱精子症分级标准;建议进行精子存活率检测、形</span><span style="color: #373737;">态学分析、阴囊超声检查、经直肠超声检查和遗传学检测等明确弱精子症的病因;推荐针对弱精子症</span><span style="color: #373737;">病因的治疗,经验性治疗以及辅助生殖技术助孕。本共识可为从事生殖医学、男科学的专业医务人员</span><span style="color: #373737;">提供专家咨询建议和诊疗参考方案。</span></p>, tagList=[TagDto(tagId=96208, tagName=弱精子症)], categoryList=[CategoryDto(categoryId=26, categoryName=泌尿外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=96208, guiderKeyword=弱精子症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=5052, appHits=132, showAppHits=0, pcHits=1678, showPcHits=4918, likes=1, shares=15, comments=8, approvalStatus=1, publishedTime=Wed Sep 29 00:47:26 CST 2021, publishedTimeString=2021-07-30, pcVisible=1, appVisible=1, editorId=5579292, editor=FUNNYMAN, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=4, createdBy=null, createdName=FUNNYMAN, createdTime=Mon Sep 27 23:43:42 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Fri Jan 05 04:18:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=弱精子症诊疗中国专家共识.pdf)])
弱精子症诊疗中国专家共识.pdf
下载请点击:
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2148960, encodeId=1cb02148960f1, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeeb2612341, createdName=xiaruijing, createdTime=Thu Jul 20 11:05:45 CST 2023, time=2023-07-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1191885, encodeId=b9e61191885a9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:47:27 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079062, encodeId=4be310e906281, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951a5116951, createdName=14629447m07暂无昵称, createdTime=Sat Dec 11 15:34:03 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074839, encodeId=f4e610e48394f, content=签到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Sun Nov 28 20:12:17 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055633, encodeId=85f0105563381, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:30:47 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2023-07-20 xiaruijing 来自浙江省

    好文章

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2148960, encodeId=1cb02148960f1, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeeb2612341, createdName=xiaruijing, createdTime=Thu Jul 20 11:05:45 CST 2023, time=2023-07-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1191885, encodeId=b9e61191885a9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:47:27 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079062, encodeId=4be310e906281, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951a5116951, createdName=14629447m07暂无昵称, createdTime=Sat Dec 11 15:34:03 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074839, encodeId=f4e610e48394f, content=签到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Sun Nov 28 20:12:17 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055633, encodeId=85f0105563381, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:30:47 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2022-02-10 ms3000000493726505

    打卡

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2148960, encodeId=1cb02148960f1, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeeb2612341, createdName=xiaruijing, createdTime=Thu Jul 20 11:05:45 CST 2023, time=2023-07-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1191885, encodeId=b9e61191885a9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:47:27 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079062, encodeId=4be310e906281, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951a5116951, createdName=14629447m07暂无昵称, createdTime=Sat Dec 11 15:34:03 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074839, encodeId=f4e610e48394f, content=签到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Sun Nov 28 20:12:17 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055633, encodeId=85f0105563381, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:30:47 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-12-11 14629447m07暂无昵称

    好东西

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2148960, encodeId=1cb02148960f1, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeeb2612341, createdName=xiaruijing, createdTime=Thu Jul 20 11:05:45 CST 2023, time=2023-07-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1191885, encodeId=b9e61191885a9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:47:27 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079062, encodeId=4be310e906281, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951a5116951, createdName=14629447m07暂无昵称, createdTime=Sat Dec 11 15:34:03 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074839, encodeId=f4e610e48394f, content=签到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Sun Nov 28 20:12:17 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055633, encodeId=85f0105563381, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:30:47 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-11-28 ada昵称

    签到

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2148960, encodeId=1cb02148960f1, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=25, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=aeeb2612341, createdName=xiaruijing, createdTime=Thu Jul 20 11:05:45 CST 2023, time=2023-07-20, status=1, ipAttribution=浙江省), GetPortalCommentsPageByObjectIdResponse(id=1191885, encodeId=b9e61191885a9, content=打卡, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220210/fc0df8627f8141ff8e44709fbd350e4c/e92e03d2977547e5bb50b57a546a23b8.jpg, createdBy=1af65715393, createdName=ms3000000493726505, createdTime=Thu Feb 10 16:47:27 CST 2022, time=2022-02-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079062, encodeId=4be310e906281, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=37, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=951a5116951, createdName=14629447m07暂无昵称, createdTime=Sat Dec 11 15:34:03 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1074839, encodeId=f4e610e48394f, content=签到, beContent=null, objectType=guider, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211126/ed525419364c40fabe9c492f1ab14454/f2d7e053250e42978439ecba216fc77c.jpg, createdBy=2e465079378, createdName=ada昵称, createdTime=Sun Nov 28 20:12:17 CST 2021, time=2021-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055633, encodeId=85f0105563381, content=好文章, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cfc84293490, createdName=13f0c37dm61暂无昵称, createdTime=Tue Sep 28 11:30:47 CST 2021, time=2021-09-28, status=1, ipAttribution=)]
    2021-09-28 13f0c37dm61暂无昵称

    好文章

    0